Skip to main content
Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.
A pilot randomized trial of red blood cell transfusion for acute treatment of vaso-occlusive pain episodes in sickle cell anaemia.
Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients.
Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major.
Pain in thalassaemia: the effects of age on pain frequency and severity.
Increased leucocyte apoptosis in transfused ß-thalassaemia patients.
Pulmonary function in thalassaemia major and its correlation with body iron stores.
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease.
Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes.
A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.